Cellectar Biosciences, Inc. — Director's Dealing 2020

Mar 5, 2020

SEC Form 4/A — Form 4/A

Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2020-02-03

Reporting Person: CARUSO JAMES V (Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-03	Stock option (right to buy)	$2.71	A	100000	Acquired	2030-02-03	Common Stock (100000)	Direct

Footnotes

F1: This Form 4/A is being filed to correct a Form 4 filed on February 4, 2020, in which the stock option grant was reported as a common stock grant. The underlying value of the award remains unchanged.

F2: Stock options vest in equal annual increments on February 3, 2021, February 3, 2022, and February 3, 2023.